CLASS II ONGOING Device recall · Reported 9 Sep 2026 · FDA Enforcement Report

STA Staclot Protein recalled by Diagnostica Stago

Diagnostica Stago is recalling STA Staclot Protein S, distributed nationwide in the US. The recall was initiated on 29 Jul 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027
Quantity recalled5220 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3047-2026
FDA event ID
99531
Recalling firm
Diagnostica Stago, Parsippany, NJ
Classification
Class II
Status
Ongoing
Recall initiated
29 Jul 2026
FDA classified
28 Aug 2026
Reported
9 Sep 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

29 Jul 2026Recall initiated by company
28 Aug 2026Classified by FDA+30 days
9 Sep 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test

Where it was distributed

US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR.

Nationwide AlabamaCaliforniaColoradoFloridaGeorgiaIllinoisMissouriNebraskaNew JerseyNew YorkOhioPennsylvaniaPuerto RicoTennesseeTexasUtahVirginia

Questions about this recall

Why was it recalled?

A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

Which lots are affected?

UDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027

Where was it sold?

US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Diagnostica Stago

All 27

Other Test Kits & Diagnostics recalls

All 2,661